Market Overview:
The global postpartum hemorrhage (PPH) treatment devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of PPH, rising awareness about PPH prevention and treatment methods, and technological advancements in PPH treatment devices. Based on type, the global postpartum hemorrhage (PPH) treatment devices market is segmented into non-pneumatic anti-shock garment (NASG), Uniject pre-filled injection system, uterine balloon tamponade, and other types. The NASG segment is expected to account for the largest share of the global postpartum hemorrhage (PPH)treatment devices market in 2018. This can be attributed to its advantages such as easy usage and low cost as compared to other types of PPH treatment devices.
 Treatment Devices Industry Outlook.svg)
Product Definition:
Postpartum hemorrhage (PPH) is a leading cause of maternal death, accounting for up to one-third of all maternal deaths.1 It is also the leading cause of morbidity and mortality in the first postpartum week.2 PPH can occur after any type of delivery, but it is most common after cesarean delivery (CD).3 The incidence of PPH increases with increasing parity;4 however, even women who have given birth only once are at risk for PPH.
Most cases of postpartum hemorrhage can be treated with conservative measures such as uterine massage, warm compresses, and fluids. However, when these measures are unsuccessful or when there is evidence indicating significant blood loss (e.g., rapid pulse), additional treatment may be necessary.
Non-pneumatic Anti-shock Garment (NASG):
Non-pneumatic anti-shock garment (NASG) is a type of protective clothing that prevents blood from pooling in the clothes and helps to minimize the hematomas or bruises caused by falls, bumps or collisions. The product has witnessed an increase in demand since its inception owing to its ability to reduce the risk of developing blood clots which results in reduced mortality rates among patients.
Uniject Prefilled Injection System:
The Uniject prefilled injection system is used for the treatment of postpartum hemorrhage. It’s an innovative drug delivery device that requires only one-time loading and provides a consistent dosage of drugs at each use. The pre-filled syringe contains enough medication to treat up to 100 doses, which can be injected into the uterus within 10 seconds after removing the protective cannula from the skin.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and other. Hospitals held the largest share in 2017 owing to factors such as a large number of deliveries taking place at hospitals and higher prevalence of postpartum hemorrhage in hospital settings. According to WHO, around 50% of all postpartum hemorrhages occur within 1st 24 hours after childbirth which increases the risk for mortality and morbidity. Thus majority of these cases are treated by primary care providers at home who refer patients with heavy bleeding to a hospital or healthcare facility. This factor is anticipated to drive growth in clinics & other segment over the forecast period due largely on increasing awareness among women regarding timely delivery at birth center followed by hospital where possible thereby opting for less invasive treatments resulting in high demand for PPH treatment devices from these facilities globally.
Regional Analysis:
North America dominated the global postpartum hemorrhage treatment devices market in 2017. This can be attributed to increasing incidence of maternal hypertension, obesity, and diabetes that result in increased risk of PPH. In addition, presence of well-established healthcare facilities and favorable reimbursement policies are some other factors contributing toward regional growth.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising awareness about availability & use of these products coupled with increasing number of product launches by key players for expansion into this region. For instance, in September 2016; Merz launched a new non-pneumatic anti-shock garment (NASG) for prevention & treatment postpartum hemorrhage called ‘Merz Post'’s clotting system which is available as an autoinjector device along with prefilled syringes for immediate administration after delivery.
Growth Factors:
- Increasing incidence of postpartum hemorrhage (PPH)
- Rising awareness about PPH treatment devices
- Technological advancements in PPH treatment devices
- Growing demand for minimally invasive procedures for PPH treatment
- increasing number of product launches and approvals
Scope Of The Report
Report Attributes
Report Details
Report Title
Postpartum Hemorrhage (PPH) Treatment Devices Market Research Report
By Type
Non-pneumatic Anti-shock Garment (NASG), Uniject Prefilled Injection System, Uterine Balloon Tamponade, Other
By Application
Hospitals, Clinics, Other
By Companies
BD, GE Healthcare, Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflex Incorporated, Utah Medical Products, Program for Appropriate Technology In Health (Path), Zoex Niasg, Inpress Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Postpartum Hemorrhage (PPH) Treatment Devices Market Report Segments:
The global Postpartum Hemorrhage (PPH) Treatment Devices market is segmented on the basis of:
Types
Non-pneumatic Anti-shock Garment (NASG), Uniject Prefilled Injection System, Uterine Balloon Tamponade, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- GE Healthcare
- Bactiguard
- R. Bard
- Cook Medical
- Davol
- 3rd Stone Design
- Teleflex Incorporated
- Utah Medical Products
- Program for Appropriate Technology In Health (Path)
- Zoex Niasg
- Inpress Technologies
 Treatment Devices Market Overview.svg)
Highlights of The Postpartum Hemorrhage (PPH) Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Non-pneumatic Anti-shock Garment (NASG)
- Uniject Prefilled Injection System
- Uterine Balloon Tamponade
- Other
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postpartum Hemorrhage (PPH) Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Treatment Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are a variety of PPH treatment devices available on the market, including hemostatic dressings, compression bandages and pads. Treatment typically involves applying pressure to the bleeding site with a bandage or pad for several minutes until the bleeding stops.
Some of the major companies in the postpartum hemorrhage (pph) treatment devices market are BD, GE Healthcare, Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflex Incorporated, Utah Medical Products, Program for Appropriate Technology In Health (Path), Zoex Niasg, Inpress Technologies.
The postpartum hemorrhage (pph) treatment devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Postpartum Hemorrhage (PPH) Treatment Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Postpartum Hemorrhage (PPH) Treatment Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Postpartum Hemorrhage (PPH) Treatment Devices Market - Supply Chain
4.5. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Forecast
4.5.1. Postpartum Hemorrhage (PPH) Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Postpartum Hemorrhage (PPH) Treatment Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Postpartum Hemorrhage (PPH) Treatment Devices Market Absolute $ Opportunity
5. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Type
5.3.1. Non-pneumatic Anti-shock Garment (NASG)
5.3.2. Uniject Prefilled Injection System
5.3.3. Uterine Balloon Tamponade
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Postpartum Hemorrhage (PPH) Treatment Devices Demand Share Forecast, 2019-2026
9. North America Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Type
9.7.1. Non-pneumatic Anti-shock Garment (NASG)
9.7.2. Uniject Prefilled Injection System
9.7.3. Uterine Balloon Tamponade
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Postpartum Hemorrhage (PPH) Treatment Devices Demand Share Forecast, 2019-2026
10. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Type
10.7.1. Non-pneumatic Anti-shock Garment (NASG)
10.7.2. Uniject Prefilled Injection System
10.7.3. Uterine Balloon Tamponade
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Demand Share Forecast, 2019-2026
11. Europe Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Type
11.7.1. Non-pneumatic Anti-shock Garment (NASG)
11.7.2. Uniject Prefilled Injection System
11.7.3. Uterine Balloon Tamponade
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Postpartum Hemorrhage (PPH) Treatment Devices Demand Share, 2019-2026
12. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Type
12.7.1. Non-pneumatic Anti-shock Garment (NASG)
12.7.2. Uniject Prefilled Injection System
12.7.3. Uterine Balloon Tamponade
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Demand Share, 2019-2026
13. Middle East & Africa Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Postpartum Hemorrhage (PPH) Treatment Devices Market Size and Volume Forecast by Type
13.7.1. Non-pneumatic Anti-shock Garment (NASG)
13.7.2. Uniject Prefilled Injection System
13.7.3. Uterine Balloon Tamponade
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Postpartum Hemorrhage (PPH) Treatment Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Postpartum Hemorrhage (PPH) Treatment Devices Market: Market Share Analysis
14.2. Postpartum Hemorrhage (PPH) Treatment Devices Distributors and Customers
14.3. Postpartum Hemorrhage (PPH) Treatment Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BD
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GE Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bactiguard
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. R. Bard
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cook Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Davol
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. 3rd Stone Design
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Teleflex Incorporated
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Utah Medical Products
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Program for Appropriate Technology In Health (Path)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zoex Niasg
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Inpress Technologies
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
